Latest ANDA aproval News
Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final…
By
RAJLAXMI
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final…
Sign in to your account